You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
|
---|---|
Published in |
Journal of Hematology & Oncology, March 2012
|
DOI | 10.1186/1756-8722-5-12 |
Pubmed ID | |
Authors |
Véronique Gelsi-Boyer, Mandy Brecqueville, Raynier Devillier, Anne Murati, Marie-Joelle Mozziconacci, Daniel Birnbaum |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 267 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Unknown | 265 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 47 | 18% |
Researcher | 38 | 14% |
Student > Master | 34 | 13% |
Other | 26 | 10% |
Student > Bachelor | 23 | 9% |
Other | 42 | 16% |
Unknown | 57 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 75 | 28% |
Medicine and Dentistry | 70 | 26% |
Agricultural and Biological Sciences | 39 | 15% |
Immunology and Microbiology | 5 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 1% |
Other | 12 | 4% |
Unknown | 62 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 74. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2021.
All research outputs
#494,709
of 22,994,508 outputs
Outputs from Journal of Hematology & Oncology
#23
of 1,198 outputs
Outputs of similar age
#2,341
of 161,325 outputs
Outputs of similar age from Journal of Hematology & Oncology
#1
of 7 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,198 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,325 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them